Found: 30
Select item for more details and to access through your institution.
Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis.
- Published in:
- Allergy & Asthma Proceedings, 2023, v. 44, n. 4, p. 265, doi. 10.2500/aap.2023.44.230015
- By:
- Publication type:
- Article
Data Mining of Free-Text Responses: An Innovative Approach to Analyzing Patient Perspectives on Treatment for Chronic Rhinosinusitis with Nasal Polyps in a Phase IIa Proof-of-Concept Study for Dupilumab.
- Published in:
- Patient Preference & Adherence, 2021, v. 15, p. 2577, doi. 10.2147/PPA.S320242
- By:
- Publication type:
- Article
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies.
- Published in:
- Allergy, 2022, v. 77, n. 7, p. 2211, doi. 10.1111/all.15222
- By:
- Publication type:
- Article
Exploring the potential of arecanut fibers and fly ash in enhancing the performance of self-compacting concrete.
- Published in:
- Journal of Engineering & Applied Science, 2024, v. 71, n. 1, p. 1, doi. 10.1186/s44147-024-00513-8
- By:
- Publication type:
- Article
Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps.
- Published in:
- Clinical & Translational Immunology, 2023, v. 12, n. 1, p. 1, doi. 10.1002/cti2.1433
- By:
- Publication type:
- Article
Improvement in patient‐reported "taste" and association with smell in dupilumab‐treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS‐24 and SINUS‐52 trials.
- Published in:
- Clinical & Experimental Allergy, 2022, v. 52, n. 9, p. 1105, doi. 10.1111/cea.14194
- By:
- Publication type:
- Article
Content validity of a newly developed observer-reported measure for pediatric asthma in children aged 2–5 years.
- Published in:
- Journal of Patient-Reported Outcomes, 2022, v. 6, n. 1, p. 1, doi. 10.1186/s41687-022-00461-y
- By:
- Publication type:
- Article
Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
- Published in:
- American Journal of Rhinology & Allergy, 2022, v. 36, n. 6, p. 788, doi. 10.1177/19458924221112211
- By:
- Publication type:
- Article
Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma.
- Published in:
- Journal of Asthma & Allergy, 2024, v. 17, p. 1, doi. 10.2147/JAA.S420140
- By:
- Publication type:
- Article
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial.
- Published in:
- Journal of Asthma & Allergy, 2023, v. 16, p. 323, doi. 10.2147/JAA.S372598
- By:
- Publication type:
- Article
Impact of Baseline Lung Function on Future Exacerbations in Patients with Moderate-to-Severe Asthma.
- Published in:
- Journal of Asthma & Allergy, 2022, v. 15, p. 1639, doi. 10.2147/JAA.S375134
- By:
- Publication type:
- Article
Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study.
- Published in:
- Journal of Asthma & Allergy, 2022, v. 15, p. 767, doi. 10.2147/JAA.S363527
- By:
- Publication type:
- Article
Rapid and Continuing Improvements in Nasal Symptoms with Dupilumab in Patients with Severe CRSwNP.
- Published in:
- Journal of Asthma & Allergy, 2022, v. 15, p. 557, doi. 10.2147/JAA.S355391
- By:
- Publication type:
- Article
Association Between a Type 2 Inflammatory Disease Burden Score and Outcomes Among Patients with Asthma.
- Published in:
- Journal of Asthma & Allergy, 2021, v. 14, p. 1173, doi. 10.2147/JAA.S321212
- By:
- Publication type:
- Article
Reducing Fungal Exposure Critical for Treating Rhinosinusitis with or without Polyps [Response to Letter].
- Published in:
- Journal of Asthma & Allergy, 2021, v. 14, p. 393, doi. 10.2147/JAA.S314846
- By:
- Publication type:
- Article
Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps.
- Published in:
- Journal of Asthma & Allergy, 2021, v. 14, p. 127, doi. 10.2147/JAA.S290424
- By:
- Publication type:
- Article
Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINUS‐52.
- Published in:
- International Forum of Allergy & Rhinology, 2024, v. 14, n. 3, p. 668, doi. 10.1002/alr.23249
- By:
- Publication type:
- Article
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials
- Published in:
- International Forum of Allergy & Rhinology, 2022, v. 12, n. 9, p. 1191, doi. 10.1002/alr.22964
- By:
- Publication type:
- Article
Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps.
- Published in:
- International Forum of Allergy & Rhinology, 2022, v. 12, n. 7, p. 958, doi. 10.1002/alr.22944
- By:
- Publication type:
- Article
Content Validation of Patient-Reported Sleep Measures and Development of a Conceptual Model of Sleep Disturbance in Patients with Moderate-to-Severe, Uncontrolled Asthma.
- Published in:
- Patient Related Outcome Measures, 2023, v. 14, p. 57, doi. 10.2147/PROM.S392666
- By:
- Publication type:
- Article
Prevalence and Severity Distribution of Type 2 Inflammation-Related Comorbidities Among Patients with Asthma, Chronic Rhinosinusitis with Nasal Polyps, and Atopic Dermatitis.
- Published in:
- Lung, 2023, v. 201, n. 1, p. 57, doi. 10.1007/s00408-023-00603-z
- By:
- Publication type:
- Article
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps.
- Published in:
- Otolaryngology-Head & Neck Surgery, 2024, v. 170, n. 4, p. 1173, doi. 10.1002/ohn.627
- By:
- Publication type:
- Article
Development of Sinonasal Outcome Test (SNOT‐22) Domains in Chronic Rhinosinusitis With Nasal Polyps.
- Published in:
- Laryngoscope, 2022, v. 132, n. 5, p. 933, doi. 10.1002/lary.29766
- By:
- Publication type:
- Article
Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds.
- Published in:
- Laryngoscope, 2022, v. 132, n. 2, p. 259, doi. 10.1002/lary.29911
- By:
- Publication type:
- Article
Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis.
- Published in:
- Laryngoscope, 2022, v. 132, n. 2, p. 265, doi. 10.1002/lary.29888
- By:
- Publication type:
- Article
Rapid and Sustained Improvement in Sense of Smell With Dupilumab in Patients With Severe Chronic Rhinosinusitis With Nasal Polyps and 0, 1, 2, or ≥3 Prior Sinonasal Surgeries (SNS): Pooled Results From the SINUS-24 and SINUS-52 Phase 3 Studies.
- Published in:
- Rhinology Supplement, 2021, v. 61, p. 587
- By:
- Publication type:
- Article
The prevalence of type 2 inflammatory signatures in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials, SINUS-24 and SINUS-52.
- Published in:
- Rhinology Supplement, 2021, v. 61, p. 351
- By:
- Publication type:
- Article
Effect of dupilumab versus placebo across various responder definitions for improvement in nasal congestion (NC) and loss of smell (LoS) scores among patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
- Published in:
- Rhinology Supplement, 2021, v. 61, p. 92
- By:
- Publication type:
- Article
The relationship of sinus opacification, olfaction and dupilumab efficacy in patients with CRSwNP.
- Published in:
- Rhinology, 2023, v. 61, n. 6, p. 531, doi. 10.4193/Rhin22.220
- By:
- Publication type:
- Article
Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP.
- Published in:
- Rhinology, 2021, v. 59, n. 3, p. 301, doi. 10.4193/Rhin20.415
- By:
- Publication type:
- Article